Artificial Intelligence is fastest growing segment fueling the growth of PCOS diagnostic Market

 

The global PCOS diagnostic Market is estimated to be valued at US$ 710.0 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
PCOS (Polycystic Ovary Syndrome) diagnostic includes hormonal tests, ultrasound, and genetic tests to screen and diagnose Polycystic Ovary Syndrome in women. Diagnosing PCOS helps in early detection and timely treatment of symptoms such as irregular periods, excess hair growth, acne, weight gain etc.

Market key trends:
One of the key trends in the PCOS diagnostic market is the increasing adoption of artificial intelligence and deep learning techniques. AI aids in analyzing ultrasound images and detecting ovarian cysts and abnormalities in ovarian structure more accurately. AI helps radiologists and sonographers arrive at faster and more precise diagnosis by flagging suspicious areas requiring a second opinion. This reduces diagnosis time and improves patient outcomes.
Segment Analysis
The global PCOS diagnostic market is segmented based on type of test, end user, and region. Based on type of test, the market is segmented into ovarian imaging, ovarian drilling, and other diagnostic tests. Ovarian imaging holds the largest market share as it is the most common and widely preferred test to diagnose PCOS. Ovarian imaging helps visualize the ovaries and measure their size, count follicles, and detect cysts which are key indicators of PCOS.

Key Takeaways
The global PCOS diagnostic market is expected to witness high growth, exhibiting a CAGR of 5.3% over the forecast period, due to increasing awareness about PCOS diagnosis and management.

The North American region dominates the global PCOS diagnostic market with the highest market share owing to strong healthcare infrastructure and high awareness levels about PCOS diagnosis in the region. Europe is the second largest regional market for PCOS diagnostic due to growing emphasis on women's health management. Asia Pacific is expected to witness the highest growth rate over the forecast period due to rising medical tourism and increasing healthcare expenditure in emerging economies like China and India.

Key players operating in the PCOS diagnostic market are AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi, Regeneron Pharmaceuticals, and Inc., Alimera Sciences. Major players are focusing on new product approvals and launches as well as expansion of manufacturing facilities to strengthen their market position.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more